Dual Antidiabetic Combination
Contains Metformin, a biguanide that improves insulin sensitivity, and Glimepiride, a sulfonylurea that stimulates pancreatic insulin secretion, providing complementary glucose-lowering effects.
Loading...
Loading...
Metformin Hcl. 500mg +Glimpride 1 mg (Bilayered Tablets)
A dual-action oral antidiabetic formulation designed for effective management of type 2 diabetes mellitus. STELTOG-G1 combines metformin and glimepiride in a bilayered tablet to improve glycemic control by enhancing insulin secretion and reducing hepatic glucose production.
A dual-action oral antidiabetic formulation designed for effective management of type 2 diabetes mellitus. STELTOG-G1 combines metformin and glimepiride in a bilayered tablet to improve glycemic control by enhancing insulin secretion and reducing hepatic glucose production.
Contains Metformin, a biguanide that improves insulin sensitivity, and Glimepiride, a sulfonylurea that stimulates pancreatic insulin secretion, providing complementary glucose-lowering effects.
Glimepiride promotes insulin release from pancreatic beta cells, helping reduce elevated blood glucose levels, particularly after meals.
Metformin decreases glucose production in the liver and improves peripheral glucose uptake, resulting in improved insulin sensitivity and better glycemic control.
Bilayered formulation allows controlled and effic...
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
